Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other financing activities: 2014-2022

Historic Other financing activities for Editas Medicine (EDIT) over the last 9 years, with Dec 2022 value amounting to $979,000.

  • Editas Medicine's Other financing activities fell 30.23% to $367,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $1.5 million, marking a year-over-year increase of 0.33%. This contributed to the annual value of $979,000 for FY2022, which is 15.02% down from last year.
  • Per Editas Medicine's latest filing, its Other financing activities stood at $979,000 for FY2022, which was down 15.02% from $1.2 million recorded in FY2021.
  • Over the past 5 years, Editas Medicine's Other financing activities peaked at $1.2 million during FY2021, and registered a low of $620,000 during FY2019.
  • In the last 3 years, Editas Medicine's Other financing activities had a median value of $979,000 in 2022 and averaged $1.0 million.
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 60.00% in 2018, then soared by 44.52% in 2020.
  • Over the past 5 years, Editas Medicine's Other financing activities (Yearly) stood at $680,000 in 2018, then decreased by 8.82% to $620,000 in 2019, then spiked by 44.52% to $896,000 in 2020, then rose by 28.57% to $1.2 million in 2021, then decreased by 15.02% to $979,000 in 2022.